Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura H Tang

Showing results (51-60 of 172) with videos related to

Pageof 18
Sort By:
Cell Death and Differentiation|June 5, 2019
Two well-differentiated pancreatic neuroendocrine tumor mouse modelsChung Wong, Laura H Tang, Christian Davidson, et al.
European Journal of Human Genetics : EJHG|February 23, 2021
Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) VariantZarina Yelskaya, Angela G Arnold, Vanessa J Marcell, et al.
European Journal of Human Genetics : EJHG|April 28, 2021
Correction to: Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) variantZarina Yelskaya, Angela G Arnold, Vanessa J Marcell, et al.
Genes & Cancer|September 28, 2010
Gene Amplifications in Well-Differentiated Pancreatic Neuroendocrine Tumors Inactivate the p53 PathwayWenwei Hu, Zhaohui Feng, Ippolito Modica, et al.
Genes & Cancer|October 16, 2010
Association of nuclear localization of a long interspersed nuclear element-1 protein in breast tumors with poor prognostic outcomesChris R Harris, Robin Normart, Qifeng Yang, et al.
Annals of Surgical Oncology|September 29, 2024
Disappearing Signet Ring Cell Adenocarcinoma in Gastric Cancer PatientsAravind Sreeram, Emily E Stroobant, Monika Laszkowska, et al.
Virchows Archiv : an International Journal of Pathology|June 8, 2006
Extranodal follicular dendritic cell sarcoma: clinical, pathologic, and histogenetic characteristics of an underrecognized disease entityJinru Shia, Wen Chen, Laura H Tang, et al.
Pancreas|October 21, 2016
Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly DifferentiatedNitya Raj, Emily Valentino, Marinela Capanu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 12, 2011
MET expression and amplification in patients with localized gastric cancerYelena Y Janjigian, Laura H Tang, Daniel G Coit, et al.
Annals of Surgical Oncology|September 4, 2009
Defining surgical indications for type I gastric carcinoid tumorRebecca A Gladdy, Vivian E Strong, Daniel Coit, et al.
Pageof 18

Showing results (51-60 of 172) with videos related to

Sort By:
Pageof 18
Cell Death and Differentiation|June 5, 2019
Two well-differentiated pancreatic neuroendocrine tumor mouse modelsChung Wong, Laura H Tang, Christian Davidson, et al.
European Journal of Human Genetics : EJHG|February 23, 2021
Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) VariantZarina Yelskaya, Angela G Arnold, Vanessa J Marcell, et al.
European Journal of Human Genetics : EJHG|April 28, 2021
Correction to: Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) variantZarina Yelskaya, Angela G Arnold, Vanessa J Marcell, et al.
Genes & Cancer|September 28, 2010
Gene Amplifications in Well-Differentiated Pancreatic Neuroendocrine Tumors Inactivate the p53 PathwayWenwei Hu, Zhaohui Feng, Ippolito Modica, et al.
Genes & Cancer|October 16, 2010
Association of nuclear localization of a long interspersed nuclear element-1 protein in breast tumors with poor prognostic outcomesChris R Harris, Robin Normart, Qifeng Yang, et al.
Annals of Surgical Oncology|September 29, 2024
Disappearing Signet Ring Cell Adenocarcinoma in Gastric Cancer PatientsAravind Sreeram, Emily E Stroobant, Monika Laszkowska, et al.
Virchows Archiv : an International Journal of Pathology|June 8, 2006
Extranodal follicular dendritic cell sarcoma: clinical, pathologic, and histogenetic characteristics of an underrecognized disease entityJinru Shia, Wen Chen, Laura H Tang, et al.
Pancreas|October 21, 2016
Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly DifferentiatedNitya Raj, Emily Valentino, Marinela Capanu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 12, 2011
MET expression and amplification in patients with localized gastric cancerYelena Y Janjigian, Laura H Tang, Daniel G Coit, et al.
Annals of Surgical Oncology|September 4, 2009
Defining surgical indications for type I gastric carcinoid tumorRebecca A Gladdy, Vivian E Strong, Daniel Coit, et al.
Pageof 18